{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T02:28:45Z","timestamp":1781922525114,"version":"3.54.5"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007512","name":"Universitat Rovira i Virgili","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007512","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Since the reports of the first cases of COVID-19, in less than 5\u00a0years, a huge number of documents regarding that disease and the coronavirus (SARS-CoV-2), responsible for the infection, have been published. The tremendous number of scientific documents covers many topics on different issues directly related to COVID-19\/SARS-CoV-2. The number of articles\u2014including reviews\u2014reporting adverse\/side effects of the approved COVID-19 vaccines is considerable. A wide range of adverse\/side effects have been reported in humans after COVID-19 vaccination: thrombotic events\/thrombocytopenia, myocarditis\/pericarditis, cutaneous reactions, immune-mediated effects, psychiatric adverse events, systemic lupus erythematosus, reproductive toxicity, and other miscellaneous adverse effects. In contrast, information on nonclinical studies conducted to assess the potential toxicity\/adverse effects of the COVID-19 vaccines in laboratory animals, is comparatively very scarce. The present review was aimed at revising the scientific literature regarding the studies in laboratory animals on the toxic\/adverse effects of COVID-19 vaccines. In addition, the investigations reported in those specific toxicology journals with the highest impact factors have been examined one by one. The results of the present review indicate that most nonclinical\/experimental studies on the adverse\/toxic effects of the COVID-19 vaccines and\/or potential candidates showed\u2014in general terms\u2014a good safety profile. Only in some animal studies were certain adverse effects found. However, a rather surprising result has been the limited number of available (in the databases PubMed and Scopus) nonclinical studies performed by the companies that\u00a0have been the largest manufacturers of mRNA vaccines in the world. It is assumed that these studies have been conducted. However, they have not been published in scientific journals, which does not allow the judgment of the international scientific community, including toxicologists.<\/jats:p>","DOI":"10.1007\/s00204-024-03854-8","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T12:02:16Z","timestamp":1725364936000},"page":"3603-3617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A review of the scientific literature on experimental toxicity studies of COVID-19 vaccines, with special attention to publications in toxicology journals"],"prefix":"10.1007","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6647-9470","authenticated-orcid":false,"given":"Jose L.","family":"Domingo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"key":"3854_CR1","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2305","volume":"32","author":"A Abdoli","year":"2022","unstructured":"Abdoli A, Aalizadeh R, Aminianfar H, Kianmehr Z, Teimoori A, Azimi E, Emamipour N, Eghtedardoost M, Siavashi V, Jamshidi H, Hosseinpour M, Taqavian M, Jalili H (2022) Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: a preclinical study. Rev Med Virol 32:e2305","journal-title":"Rev Med Virol"},{"key":"3854_CR2","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s00204-021-03126-9","volume":"95","author":"M Arand","year":"2021","unstructured":"Arand M (2021) Opinion: a serious issue with the standardization of the adenovirus-based COVID-19 vaccines? Arch Toxicol 95:3137\u20133139","journal-title":"Arch Toxicol"},{"key":"3854_CR3","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105189","volume":"132","author":"P Baldrick","year":"2022","unstructured":"Baldrick P (2022) Development of COVID-19 therapies: nonclinical testing considerations. Regul Toxicol Pharmacol 132:105189","journal-title":"Regul Toxicol Pharmacol"},{"key":"3854_CR4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.836745","volume":"13","author":"SR Banihashemi","year":"2022","unstructured":"Banihashemi SR, Es-Haghi A, Fallah Mehrabadi MH, Nofeli M, Mokarram AR, Ranjbar A, Salman M, Hajimoradi M, Razaz SH, Taghdiri M, Bagheri M, Dadar M, Hassan ZM, Eslampanah M, Salehi Najafabadi Z, Lotfi M, Khorasani A, Rahmani F (2022) Safety and efficacy of combined intramuscular\/intranasal RAZI-COV PARS vaccine candidate against SARS-CoV-2: a preclinical study in several animal models. Front Immunol 13:836745","journal-title":"Front Immunol"},{"key":"3854_CR5","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.3390\/ijms241310514","volume":"24","author":"H Banoun","year":"2023","unstructured":"Banoun H (2023) mRNA: vaccine or gene therapy? the safety regulatory issues. Int J Mol Sci 24:10514","journal-title":"Int J Mol Sci"},{"key":"3854_CR6","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115237","volume":"406","author":"K Barali\u0107","year":"2020","unstructured":"Barali\u0107 K, Jorgovanovi\u0107 D, \u017divan\u010devi\u0107 K, Antonijevi\u0107 Miljakovi\u0107 E, Antonijevi\u0107 B, Buha Djordjevic A, \u0106ur\u010di\u0107 M, \u0110uki\u0107-\u0106osi\u0107 D (2020) Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach. Toxicol Appl Pharmacol 406:115237","journal-title":"Toxicol Appl Pharmacol"},{"key":"3854_CR7","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1021\/acs.chemrestox.1c00129","volume":"34","author":"B Barda","year":"2021","unstructured":"Barda B, Cerny A (2021) Safety of mRNA-based vaccines for SARS CoV-2. Chem Res Toxicol 34:1823\u20131825","journal-title":"Chem Res Toxicol"},{"key":"3854_CR8","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106126","volume":"26","author":"A Barreiro","year":"2023","unstructured":"Barreiro A, Prenafeta A, Bech-Sabat G, Roca M, Perozo Mur E, March R, Gonz\u00e1lez-Gonz\u00e1lez L, Madrenas L, Corominas J, Fern\u00e1ndez A, Moros A, Ca\u00f1ete M, Molas M, Pentinat-Pelegrin T, Panosa C, Moreno A, Puigvert Molas E, Pol Vilarrassa E, Palmada J, Garriga C, Prat Caba\u00f1as T, Iglesias-Fern\u00e1ndez J, Vergara-Alert J, Lorca-Or\u00f3 C, Roca N, Fern\u00e1ndez-Bastit L, Rodon J, P\u00e9rez M, Segal\u00e9s J, Pradenas E, Marfil S, Trinit\u00e9 B, Ortiz R, Clotet B, Blanco J, D\u00edaz Pedroza J, Ampudia Carrasco R, Rosales Salgado Y, Loubat-Casanovas J, Capdevila Larripa S, Prado JG, Barretina J, Sister\u00e9-Or\u00f3 M, Cebollada Rica P, Meyerhans A, Ferrer L (2023) Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2. Iscience 26:106126","journal-title":"Iscience"},{"key":"3854_CR9","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113897","volume":"178","author":"J Barri\u00e8re","year":"2023","unstructured":"Barri\u00e8re J, Frank F, Besancon L, Samuel A, Saada V, Billy E, Al-Ahmad A, Florens N, Seitz-Polski B, Robert J (2023) Letter to editor \u201cInnate immune suppression by SARS-CoV-2 mRNA vaccinations: the role of G-quadruplexes, exosomes, and MicroRNAs\u201d: important concerns on the validity of this article. Food Chem Toxicol 178:113897","journal-title":"Food Chem Toxicol"},{"key":"3854_CR10","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s10787-022-01089-6","volume":"30","author":"S Bat\u0131bay","year":"2022","unstructured":"Bat\u0131bay S, Ulucak\u00f6y RK, G\u00fcnendi Z, Fidan I, Bozday\u0131 G, G\u00f6\u011f\u00fc\u015f FN (2022) Immunogenicity and safety of the CoronaVac and BNT162b2 COVID-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines. Inflammopharmacology 30:2089\u20132096","journal-title":"Inflammopharmacology"},{"key":"3854_CR11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/toxsci\/kfab130","volume":"185","author":"I Bebenek","year":"2022","unstructured":"Bebenek I, Bannister R, Dubinion J, Fortin M, Liu M, Motter AL, Rohde CM, Wrzesinski C (2022) COVID-19 therapeutics and vaccines: a race to save lives. Toxicol Sci 185:119\u2013127","journal-title":"Toxicol Sci"},{"key":"3854_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/jfcm.jfcm_3_23","volume":"30","author":"NF Bin Rubaian","year":"2023","unstructured":"Bin Rubaian NF, Aljalfan AA, Almuhaidib SR (2023) Management of coronavirus disease 2019 vaccine-induced cutaneous complications: a comprehensive literature review. J Family Community Med 30:161\u2013170","journal-title":"J Family Community Med"},{"key":"3854_CR13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","volume":"23","author":"D Bitounis","year":"2024","unstructured":"Bitounis D, Jacquinet E, Rogers MA, Amiji MM (2024) Strategies to reduce the risks of mRNA drug and vaccine toxicity. Nat Rev Drug Discov 23:281\u2013300","journal-title":"Nat Rev Drug Discov"},{"key":"3854_CR14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.reprotox.2021.05.007","volume":"103","author":"CJ Bowman","year":"2021","unstructured":"Bowman CJ, Bouressam M, Campion SN, Cappon GD, Catlin NR, Cutler MW, Diekmann J, Rohde CM, Sellers RS, Lindemann C (2021) Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine. Reprod Toxicol 103:28\u201335","journal-title":"Reprod Toxicol"},{"key":"3854_CR15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jat.4548","volume":"44","author":"K Broudic","year":"2024","unstructured":"Broudic K, Laurent S, Perkov V, Simon C, Garinot M, Truchot N, Latour J, D\u00e9sert P (2024) Nonclinical safety assessment of an mRNA COVID-19 vaccine candidate following repeated administrations and biodistribution. J Appl Toxicol 44:371\u2013390","journal-title":"J Appl Toxicol"},{"key":"3854_CR16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/09612033241232054","volume":"33","author":"NL Cahuapaza-Gutierrez","year":"2024","unstructured":"Cahuapaza-Gutierrez NL (2024) Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series. Lupus 33:375\u2013386","journal-title":"Lupus"},{"key":"3854_CR17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40264-024-01405-9","volume":"47","author":"I Caplanusi","year":"2024","unstructured":"Caplanusi I, Szmigiel A, van der Elst M, Schougaard Christiansen ML, Thirstrup S, Zaccaria C, Cappelli B, Genov G, Straus S (2024) The role of the European Medicines Agency in the Safety Monitoring of COVID-19 vaccines and future directions in enhancing vaccine safety globally. Drug Saf 47:405\u2013418","journal-title":"Drug Saf"},{"key":"3854_CR18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13181-022-00918-y","volume":"19","author":"MA Chary","year":"2023","unstructured":"Chary MA, Barbuto AF, Izadmehr S, Tarsillo M, Fleischer E, Burns MM (2023a) COVID-19 therapeutics: use, mechanism of action, and toxicity (xenobiotics). J Med Toxicol 19:26\u201336","journal-title":"J Med Toxicol"},{"key":"3854_CR19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s13181-023-00931-9","volume":"19","author":"M Chary","year":"2023","unstructured":"Chary M, Barbuto AF, Izadmehr S, Tarsillo M, Fleischer E, Burns MM (2023b) COVID-19 therapeutics: use, mechanism of action, and toxicity (vaccines, monoclonal antibodies, and immunotherapeutics). J Med Toxicol 19:205\u2013218","journal-title":"J Med Toxicol"},{"key":"3854_CR20","doi-asserted-by":"crossref","first-page":"2252239","DOI":"10.1080\/21645515.2023.2252239","volume":"19","author":"S d\u2019Almeida","year":"2023","unstructured":"d\u2019Almeida S, Markovic S, Hermann P, Bracht H, Peifer J, Ettrich TJ, Imhof A, Zhou S, Weiss M, Viardot A, Rottbauer W, Dahme T (2023) Thromboembolism after Astra Zeneca COVID-19 vaccine: not always PF4- antibody mediated. Hum Vaccin Immunother 19:2252239","journal-title":"Hum Vaccin Immunother"},{"key":"3854_CR21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuro.2022.03.012","volume":"90","author":"TM da Luz","year":"2022","unstructured":"da Luz TM, Ara\u00fajo APDC, Rezende FNE, Silva AM, Charlie-Silva I, Braz HLB, Sanches PRS, Rahman MM, Barcel\u00f3 D, Malafaia G (2022) Shedding light on the toxicity of SARS-CoV-2-derived peptide in non-target COVID-19 organisms: a study involving inbred and outbred mice. Neurotoxicology 90:184\u2013196","journal-title":"Neurotoxicology"},{"key":"3854_CR22","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00204-021-03221-x","volume":"96","author":"X Dai","year":"2022","unstructured":"Dai X, Zhao W, Tong X, Liu W, Zeng X, Duan X, Wu H, Wang L, Huang Z, Tang X, Yang Y (2022) Non-clinical immunogenicity, biodistribution and toxicology evaluation of a chimpanzee adenovirus-based COVID-19 vaccine in rat and rhesus macaque. Arch Toxicol 96:1437\u20131453","journal-title":"Arch Toxicol"},{"issue":"2","key":"3854_CR23","doi-asserted-by":"crossref","first-page":"2252239","DOI":"10.1080\/21645515.2023.2252239","volume":"19","author":"S Dalmia","year":"2023","unstructured":"Dalmia S, Markovic S, Hermann P, Bracht H, Peifer J, Ettrich TJ, Imhof A, Zhou S, Weiss M, Viardot A, Rottbauer W, Dahme T (2023) Thromboembolism after Astra Zeneca COVID-19 vaccine: not always PF4- antibody mediated. Hum Vaccin Immunother 19(2):2252239","journal-title":"Hum Vaccin Immunother"},{"key":"3854_CR24","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.112809","volume":"160","author":"JL Domingo","year":"2022","unstructured":"Domingo JL (2022) Call for papers on potential toxic effects of COVID-19 vaccines. Food Chem Toxicol 160:112809","journal-title":"Food Chem Toxicol"},{"key":"3854_CR25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.reprotox.2021.11.006","volume":"107","author":"C Dub\u00e9","year":"2022","unstructured":"Dub\u00e9 C, Paris-Robidas S, Primakova I, Destexhe E, Ward BJ, Landry N, Tr\u00e9panier S (2022) Lack of effects on female fertility or pre- and postnatal development of offspring in rats after exposure to AS03-adjuvanted recombinant plant-derived virus-like particle vaccine candidate for COVID-19. Reprod Toxicol 107:69\u201380","journal-title":"Reprod Toxicol"},{"key":"3854_CR26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s43162-022-00129-5","volume":"34","author":"HA ElSawi","year":"2022","unstructured":"ElSawi HA, Elborollosy A (2022) Immune-mediated adverse events post-COVID vaccination and types of vaccines: a systematic review and meta-analysis. Egypt J Intern Med 34:44","journal-title":"Egypt J Intern Med"},{"key":"3854_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-024-01422-8","author":"M Gordillo-Mara\u00f1\u00f3n","year":"2024","unstructured":"Gordillo-Mara\u00f1\u00f3n M, Candore G, Hedenmalm K, Browne K, Flynn R, Piccolo L, Santoro A, Zaccaria C, Kurz X (2024a) Lessons learned on observed-to-expected analysis using spontaneous reports during mass vaccination. Drug Saf (published Online). https:\/\/doi.org\/10.1007\/s40264-024-01422-8","journal-title":"Drug Saf (published Online)"},{"key":"3854_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-024-01426-4","author":"M Gordillo-Mara\u00f1\u00f3n","year":"2024","unstructured":"Gordillo-Mara\u00f1\u00f3n M, Szmigiel A, Yalmanov\u00e1 V, Caplanusi I, Genov G, Olsen DB, Straus S (2024b) COVID-19 vaccines and heavy menstrual bleeding: the impact of media attention on reporting to EudraVigilance. Drug Saf (published Online). https:\/\/doi.org\/10.1007\/s40264-024-01426-4","journal-title":"Drug Saf (published Online)"},{"key":"3854_CR29","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1016\/j.vaccine.2023.10.025","volume":"41","author":"D Gubernot","year":"2023","unstructured":"Gubernot D, Menis M, Whitaker B (2023) Background rates for severe cutaneous reactions in the US: contextual support for safety assessment of COVID-19 vaccines and novel biologics. Vaccine 41:6922\u20136929","journal-title":"Vaccine"},{"key":"3854_CR30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/toxins15090563","volume":"15","author":"S Gupta","year":"2023","unstructured":"Gupta S, Pellett S (2023) Recent developments in vaccine design: from live vaccines to recombinant toxin vaccines. Toxins (Basel) 15:563","journal-title":"Toxins (Basel)"},{"key":"3854_CR31","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.vaccine.2022.10.009","volume":"40","author":"PM Hassan","year":"2022","unstructured":"Hassan PM, Ali T, Saber E, Asghar A, Delaram D, Mostafa SV, Maryam S, Maryam K, Talieh S, Ali KM, Mohammad P, Fereidoon K, Anahita B, Yury VB, Dagmar GR, Vicente VB, Alireza B, Kazem B (2022) Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein. Vaccine 40:2856\u20132868","journal-title":"Vaccine"},{"key":"3854_CR32","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112239","volume":"152","author":"Z Huang","year":"2021","unstructured":"Huang Z, Jiang Q, Wang Y, Yang J, Du T, Yi H, Li C, Li Y, Wu Z, Fan S, Liao Y, Zhang Y, Wang L, Jiang G, Tang D, Ye Y, Wang C, Li Z, Li Z, Zhang C, Ma K, Li Q (2021) SARS-CoV-2 inactivated vaccine (Vero cells) shows good safety in repeated administration toxicity test of Sprague Dawley rats. Food Chem Toxicol 152:112239","journal-title":"Food Chem Toxicol"},{"key":"3854_CR33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/08923973.2022.2073889","volume":"44","author":"Z Huang","year":"2022","unstructured":"Huang Z, Li Y, Yi H, Wu Z, Li C, Du T, Yang J, Wang Y, Jiang Q, Fan S, Liao Y, Zhang Y, Jiang G, Ma K, Li Q (2022) Absence of active systemic anaphylaxis in guinea pigs upon intramuscular injection of inactivated SARS-CoV-2 vaccine (Vero cells). Immunopharmacol Immunotoxicol 44:633\u2013640","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"3854_CR34","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115425","volume":"414","author":"SP Kalarikkal","year":"2021","unstructured":"Kalarikkal SP, Sundaram GM (2021) Edible plant-derived exosomal microRNAs: exploiting a cross-kingdom regulatory mechanism for targeting SARS-CoV-2. Toxicol Appl Pharmacol 414:115425","journal-title":"Toxicol Appl Pharmacol"},{"key":"3854_CR35","doi-asserted-by":"publisher","first-page":"251513552412284","DOI":"10.1177\/25151355241228439.eCollection","volume":"12","author":"SH Kanuri","year":"2024","unstructured":"Kanuri SH, Sirrkay PJ (2024) Adjuvants in COVID-19 vaccines: innocent bystanders or culpable abettors for stirring up COVID-heart syndrome. Ther Adv Vaccines Immunother 12:25151355241228440. https:\/\/doi.org\/10.1177\/25151355241228439.eCollection","journal-title":"Ther Adv Vaccines Immunother"},{"key":"3854_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-024-01432-6","author":"U Kaur","year":"2024","unstructured":"Kaur U, Jaiswal A, Jaiswal A, Singh K, Pandey A, Chauhan M, Rai M, Kansal S, Patwardhan K, Jaisawal V, Chakrabarti SS (2024) Long-term safety analysis of the BBV152 coronavirus vaccine in adolescents and adults: findings from a 1-year prospective study in North India. Drug Saf (published Online). https:\/\/doi.org\/10.1007\/s40264-024-01432-6","journal-title":"Drug Saf (published Online)"},{"key":"3854_CR37","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.2147\/JIR.S455682","volume":"17","author":"\u015e K\u00f6se","year":"2024","unstructured":"K\u00f6se \u015e, Y\u0131lmaz C, K\u0131ratl\u0131 K, \u00c7elebi \u00c7, Akan P, Kumas Kulualp M, Duman S, Y\u0131lmaz O (2024) Effects of Repeated doses of the Vero cell vaccine (SARS-Cov-2 inactivated vaccine) on renal functions in Balb\/C albino mice. J Inflamm Res 17:2851\u20132860","journal-title":"J Inflamm Res"},{"key":"3854_CR38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40265-021-01480-7","volume":"81","author":"YN Lamb","year":"2021","unstructured":"Lamb YN (2021) BNT162b2 mRNA COVID-19 vaccine: first approval. Drugs 81:495\u2013501","journal-title":"Drugs"},{"key":"3854_CR39","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.3390\/v14102188","volume":"14","author":"AE Leon","year":"2022","unstructured":"Leon AE, Garelle D, Hartwig A, Falendysz EA, Ip HS, Lankton JS, Tretten TN, Spraker TR, Bowen R, Rocke TE (2022) Immunogenicity, safety, and anti-viral efficacy of a subunit SARS-CoV-2 vaccine candidate in captive black-footed ferrets (Mustela nigripes) and their susceptibility to viral challenge. Viruses 14:2188","journal-title":"Viruses"},{"key":"3854_CR40","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/cid\/ciab707","volume":"74","author":"C Li","year":"2022","unstructured":"Li C, Chen Y, Zhao Y, Lung DC, Ye Z, Song W, Liu FF, Cai JP, Wong WM, Yip CC, Chan JF, To KK, Sridhar S, Hung IF, Chu H, Kok KH, Jin DY, Zhang AJ, Yuen KY (2022) Intravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in mouse model. Clin Infect Dis 74:1933\u20131950","journal-title":"Clin Infect Dis"},{"key":"3854_CR41","first-page":"468","volume":"25","author":"YC Ma","year":"2023","unstructured":"Ma YC, Cheng C, Yuan C, Xiang LY, Wen J, Jin X (2023) The effect of COVID-19 vaccines on sperm parameters: a systematic review and meta-analysis. Asian J Androl 25:468\u2013473","journal-title":"Asian J Androl"},{"key":"3854_CR42","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00204-021-03214-w","volume":"96","author":"N Madar-Balakirski","year":"2022","unstructured":"Madar-Balakirski N, Rosner A, Melamed S, Politi B, Steiner M, Tamir H, Yahalom-Ronen Y, Bar-David E, Ben-Shmuel A, Sittner A, Glinert I, Weiss S, Bar-Haim E, Cohen H, Elia U, Achdout H, Erez N, Rotem S, Lazar S, Nyska A, Yitzhaki S, Beth-Din A, Levy H, Paran N, Israely T, Marcus H (2022) Preliminary nonclinical safety and immunogenicity of an rVSV-\u0394G-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs. Arch Toxicol 96:859\u2013875","journal-title":"Arch Toxicol"},{"key":"3854_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2022.08.002","volume":"105","author":"M Marietta","year":"2022","unstructured":"Marietta M, Coluccio V, Luppi M (2022) Potential mechanisms of vaccine-induced thrombosis. Eur J Intern Med 105:1\u20137","journal-title":"Eur J Intern Med"},{"key":"3854_CR44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.122.000934","volume":"51","author":"ER McColl","year":"2023","unstructured":"McColl ER, Croyle MA, Zamboni WC, Honer WG, Heise M, Piquette-Miller M, Goralski KB (2023) COVID-19 vaccines and the virus: impact on drug metabolism and pharmacokinetics. Drug Metab Dispos 51:130\u2013141","journal-title":"Drug Metab Dispos"},{"key":"3854_CR45","first-page":"1663","volume":"25","author":"SA Meo","year":"2021","unstructured":"Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC (2021) COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna vaccines. Eur Rev Med Pharmacol Sci 25:1663\u20131669","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3854_CR46","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1016\/j.vaccine.2023.07.008","volume":"41","author":"A Moros","year":"2023","unstructured":"Moros A, Prenafeta A, Barreiro A, Perozo E, Fern\u00e1ndez A, Ca\u00f1ete M, Gonz\u00e1lez L, Garriga C, Pradenas E, Marfil S, Blanco J, Cebollada Rica P, Sister\u00e9-Or\u00f3 M, Meyerhans A, Prat Caba\u00f1as T, March R, Ferrer L (2023) Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate. Vaccine 41:5072\u20135078","journal-title":"Vaccine"},{"key":"3854_CR47","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/vaccines11030510","volume":"11","author":"AG Mukherjee","year":"2023","unstructured":"Mukherjee AG, Wanjari UR, Gopalakrishnan AV, Kannampuzha S, Murali R, Namachivayam A, Ganesan R, Renu K, Dey A, Vellingiri B, Prabakaran DS (2023) Insights into the scenario of SARS-CoV-2 infection in male reproductive toxicity. Vaccines (Basel) 11:510","journal-title":"Vaccines (Basel)"},{"key":"3854_CR48","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1038\/s41598-023-30473-7","volume":"13","author":"DQP Oh","year":"2023","unstructured":"Oh DQP, Grothe I, Luka\u00df H, Kreiter AK, Hoffmann M, Wegener D (2023a) Monitoring and immunogenicity of SARS-CoV-2 vaccination of laboratory rhesus monkeys (Macaca mulatta). Sci Rep 13:3274","journal-title":"Sci Rep"},{"key":"3854_CR49","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00204-023-03446-y","volume":"97","author":"S Oh","year":"2023","unstructured":"Oh S, Jang MS, Jung KJ, Han JS, Lee H, Gil A, Jeon B, Roberts CC, Maslow JN, Kim YB, Han KH (2023b) Preclinical safety assessment of the suction-assisted intradermal injection of the SARS-CoV-2 DNA vaccine candidate pGO-1002 in white rabbit. Arch Toxicol 97:1177\u20131189","journal-title":"Arch Toxicol"},{"key":"3854_CR50","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2022.153161","volume":"471","author":"R Oliva-Hern\u00e1ndez","year":"2022","unstructured":"Oliva-Hern\u00e1ndez R, Fari\u00f1as-Medina M, Hern\u00e1ndez-Salazar T, Oyarzabal-Vera A, Infante-Bourzac JF, Rodr\u00edguez-Salgueiro S, Rodr\u00edguez-Noda LM, Arranguren-Masorra Y, Climent-Ru\u00edz Y, Fern\u00e1ndez-Castillo S, G-Rivera D, Santana-Mederos D, S\u00e1nchez-Ram\u00edrez B, Garc\u00eda-Rivera D, Vald\u00e9s-Barb\u00edn Y, V\u00e9rez-Bencomo V, (2022) Repeat-dose and local tolerance toxicity of SARS-CoV-2 FINLAY-FR-02 vaccine candidate in Sprague Dawley rats. Toxicology 471:153161","journal-title":"Toxicology"},{"key":"3854_CR51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-pharmtox-121120-012309","volume":"62","author":"S Pandamooz","year":"2022","unstructured":"Pandamooz S, Jurek B, Meinung CP, Baharvand Z, Sahebi Shahem-Abadi A, Haerteis S, Miyan JA, Downing J, Dianatpour M, Borhani-Haghighi A, Salehi MS (2022) Experimental models of SARS-CoV-2 infection: possible platforms to study COVID-19 pathogenesis and potential treatments. Annu Rev Pharmacol Toxicol 62:25\u201353","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3854_CR52","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s00204-023-03549-6","volume":"97","author":"SJ Park","year":"2023","unstructured":"Park SJ, Jang MS, Lim KH, Seo JW, Im WJ, Han KH, Kim SE, Jang E, Park D, Kim YB (2023) Preclinical evaluation of general toxicity and safety pharmacology of a receptor-binding domain-based COVID-19 subunit vaccine in various animal models. Arch Toxicol 97:2429\u20132440","journal-title":"Arch Toxicol"},{"key":"3854_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-024-03746-x","author":"SJ Park","year":"2024","unstructured":"Park SJ, Park H, Back SM, Lee YJ, Seo JW, Kim D, Lee JH, Kwak C, Han KH, Son HY, Kim YB (2024) Genotoxicity and safety pharmacology of the rVSVInd(GML)-mspSGtc vaccine against SARS-CoV-2 in Sprague-Dawley rats and Beagle dogs. Arch Toxicol (published Online). https:\/\/doi.org\/10.1007\/s00204-024-03746-x","journal-title":"Arch Toxicol (published Online)"},{"key":"3854_CR54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.reprotox.2022.10.003","volume":"114","author":"SN Piekos","year":"2022","unstructured":"Piekos SN, Price ND, Hood L, Hadlock JJ (2022) The impact of maternal SARS-CoV-2 infection and COVID-19 vaccination on maternal-fetal outcomes. Reprod Toxicol 114:33\u201343","journal-title":"Reprod Toxicol"},{"key":"3854_CR55","volume":"378","author":"J Pillay","year":"2022","unstructured":"Pillay J, Gaudet L, Wingert A, Bialy L, Mackie AS, Paterson DI, Hartling L (2022) Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review. BMJ 378:e069445","journal-title":"BMJ"},{"key":"3854_CR56","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107224","volume":"26","author":"A Prenafeta","year":"2023","unstructured":"Prenafeta A, Bech-S\u00e0bat G, Moros A, Barreiro A, Fern\u00e1ndez A, Ca\u00f1ete M, Roca M, Gonz\u00e1lez-Gonz\u00e1lez L, Garriga C, Confais J, Toussenot M, Contamin H, Pizzorno A, Rosa-Calatrava M, Pradenas E, Marfil S, Blanco J, Rica PC, Sister\u00e9-Or\u00f3 M, Meyerhans A, Lorca C, Segal\u00e9s J, Prat T, March R, Ferrer L (2023) Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates. Iscience 26:107224","journal-title":"Iscience"},{"key":"3854_CR57","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40264-023-01281-9","volume":"46","author":"M Raethke","year":"2023","unstructured":"Raethke M, van Hunsel F, Thurin NH, Dureau-Pournin C, Mentzer D, Kova\u010di\u0107 B, Miro\u0161evi\u0107 Skvrce N, De Clercq E, Sabbe M, Trifir\u00f2 G, Luxi N, Giovanazzi A, Shakir S, Klungel OH, Schmikli S, Sturkenboom M (2023) Cohort event monitoring of adverse reactions to COVID-19 vaccines in seven European countries: pooled results on first dose. Drug Saf 46:391\u2013404","journal-title":"Drug Saf"},{"key":"3854_CR58","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1177\/01926233211042263","volume":"49","author":"Y Ramot","year":"2021","unstructured":"Ramot Y, Caselli G, Aurisicchio L, Andreini I, Marra E, Luberto L, Stoppoloni D, Pacello ML, Monetini L, Nyska A (2021) Toxicity and local tolerance of COVID- eVax, a plasmid DNA vaccine for SARS-CoV-2, delivered by electroporation. Toxicol Pathol 49:1255\u20131268","journal-title":"Toxicol Pathol"},{"key":"3854_CR59","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/01926233221090518","volume":"50","author":"Y Ramot","year":"2022","unstructured":"Ramot Y, Kronfeld N, Ophir Y, Ezov N, Friedman S, Saloheimo M, Vitikainen M, Ben-Artzi H, Avigdor A, Tchelet R, Valbuena Crespo N, Emalfarb M, Nyska A (2022) Toxicity and local tolerance of a novel spike protein RBD vaccine against SARS-CoV-2, produced using the C1 Thermothelomyces Heterothallica protein expression platform. Toxicol Pathol 50:294\u2013307","journal-title":"Toxicol Pathol"},{"key":"3854_CR60","volume":"16","author":"N Rasheed","year":"2024","unstructured":"Rasheed N, Khan J, Yusuf A, Khan AS, Mustajab A, Majeed R, Hashmi AA (2024) AstraZeneca COVID-19 vaccine and diabetes mellitus: a prospective clinical study regarding vaccine side effects. Cureus 16:e51583","journal-title":"Cureus"},{"key":"3854_CR61","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.15585\/mmwr.mm7032e4","volume":"70","author":"HG Rosenblum","year":"2021","unstructured":"Rosenblum HG, Hadler SC, Moulia D, Shimabukuro TT, Su JR, Tepper NK, Ess KC, Woo EJ, Mba-Jonas A, Alimchandani M, Nair N, Klein NP, Hanson KE, Markowitz LE, Wharton M, McNally VV, Romero JR, Talbot HK, Lee GM, Daley MF, Mbaeyi SA, Oliver SE (2021) Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the Advisory Committee on Immunization Practices\u2014United States, July 2021. MMWR Morb Mortal Wkly Rep 70:1094\u20131099","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3854_CR62","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00204-022-03302-5","volume":"96","author":"A Rosner","year":"2022","unstructured":"Rosner A, Steiner M, Melamed S, Politi B, Vitner E, Tamir H, Achdout H, Cherry L, Avraham R, Yahalom-Ronen Y, Levy H, Beth-Din A, Stein D, Mechaly A, Fisher M, Fatelevich E, Weiss S, Kronfeld N, Madar-Shapiro L, Nyska A, Yitzhaki S, Paran N, Israely T, Marcus H, Madar-Balakirski N (2022) rVSV-\u0394G-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits. Arch Toxicol 96:2329\u20132339","journal-title":"Arch Toxicol"},{"key":"3854_CR63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.24171\/j.phrp.2023.0325","volume":"15","author":"S Ryoo","year":"2024","unstructured":"Ryoo S, Choi M, Choi NK, Shin HS, Woo JH, Park BJ, Oh S (2024) Psychiatric adverse events associated with the COVID-19 vaccines approved in the Republic of Korea: a systematic review. Osong Public Health Res Perspect 15:107\u2013114","journal-title":"Osong Public Health Res Perspect"},{"key":"3854_CR64","volume":"142","author":"NKM Schilder","year":"2023","unstructured":"Schilder NKM, Tiesjema B, Theunissen PT, Rengerink KO, van der Laan JW (2023) Evaluation of non-clinical toxicity studies of COVID-19 vaccines. Regul Toxicol Pharmacol 142:105438","journal-title":"Regul Toxicol Pharmacol"},{"key":"3854_CR65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/bph.16262","volume":"181","author":"R Schreckenberg","year":"2024","unstructured":"Schreckenberg R, Woitasky N, Itani N, Czech L, Ferdinandy P, Schulz R (2024) Cardiac side effects of RNA-based SARS-CoV-2 vaccines: hidden cardiotoxic effects of mRNA-1273 and BNT162b2 on ventricular myocyte function and structure. Br J Pharmacol 181:345\u2013361","journal-title":"Br J Pharmacol"},{"key":"3854_CR66","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1007\/s10787-023-01204-1","volume":"31","author":"S Seb\u0151k","year":"2023","unstructured":"Seb\u0151k S, Gyires K (2023) Long COVID and possible preventive options. Inflammopharmacology 31:2807\u20132817","journal-title":"Inflammopharmacology"},{"key":"3854_CR67","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113008","volume":"164","author":"S Seneff","year":"2022","unstructured":"Seneff S, Nigh G, Kyriakopoulos AM, McCullough PA (2022) Innate immune suppression by SARS-CoV-2 mRNA vaccinations: the role of G-quadruplexes, exosomes, and MicroRNAs. Food Chem Toxicol 164:113008","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"3854_CR68","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3390\/ijms25031469","volume":"25","author":"AA Seyhan","year":"2024","unstructured":"Seyhan AA (2024) Trials and tribulations of microRNA therapeutics. Int J Mol Sci 25(3):1469","journal-title":"Int J Mol Sci"},{"key":"3854_CR69","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1016\/j.vaccine.2022.05.087","volume":"40","author":"B Shanmugaraj","year":"2022","unstructured":"Shanmugaraj B, Khorattanakulchai N, Panapitakkul C, Malla A, Im-Erbsin R, Inthawong M, Sunyakumthorn P, Hunsawong T, Klungthong C, Reed MC, Kemthong T, Suttisan N, Malaivijitnond S, Srimangkornkaew P, Klinkhamhom A, Manopwisedjaroen S, Thitithanyanont A, Taychakhoonavudh S, Phoolcharoen W (2022) Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: protective efficacy, immunogenicity, safety, and toxicity. Vaccine 40:4440\u20134452","journal-title":"Vaccine"},{"key":"3854_CR70","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-pharmtox-061220-093932","volume":"61","author":"H Sivaraman","year":"2021","unstructured":"Sivaraman H, Er SY, Choong YK, Gavor E, Sivaraman J (2021) Structural basis of SARS-CoV-2- and SARS-CoV-receptor binding and small-molecule blockers as potential therapeutics. Annu Rev Pharmacol Toxicol 61:465\u2013493","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3854_CR71","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.reprotox.2021.07.010","volume":"104","author":"R Stebbings","year":"2021","unstructured":"Stebbings R, Maguire S, Armour G, Jones C, Goodman J, Maguire AK, Tang CM, Skellett V, Harris J (2021) Developmental and reproductive safety of AZD1222 (ChAdOx1 nCoV-19) in mice. Reprod Toxicol 104:134\u2013142","journal-title":"Reprod Toxicol"},{"key":"3854_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-024-02039-y","author":"YY Syed","year":"2024","unstructured":"Syed YY (2024) Ensitrelvir fumaric acid: first approval. Drugs (published Online). https:\/\/doi.org\/10.1007\/s40265-024-02039-y","journal-title":"Drugs (published Online)"},{"key":"3854_CR73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/15563650.2022.2147272","volume":"61","author":"Y Tadfor","year":"2023","unstructured":"Tadfor Y, Nguyen-Hua N, Bennett H, Bos AJ, Smolinske SC (2023) An observational study of adverse drug reactions to COVID-19 vaccines reported to the New Mexico poison center hotline. Clin Toxicol 61:77\u201383","journal-title":"Clin Toxicol"},{"key":"3854_CR74","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1016\/j.scib.2023.11.024","volume":"68","author":"S Tan","year":"2023","unstructured":"Tan S, Zhao J, Hu X, Li Y, Wu Z, Lu G, Yu Z, Du B, Liu Y, Li L, Chen Y, Li Y, Yao Y, Zhang X, Rao J, Gao G, Peng Y, Liu H, Yuan Z, Liu J, Wang Q, Hu H, Gao X, Zhou H, Yu H, Xu Y, Yu W, Feng L, Wang M, Shan C, Lu J, Lin J (2023) Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants. Sci Bull (Beijing) 68:3192\u20133206","journal-title":"Sci Bull (Beijing)"},{"key":"3854_CR75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.837629","volume":"13","author":"G Uzun","year":"2022","unstructured":"Uzun G, Pelzl L, Singh A, Bakchoul T (2022) Immune-mediated platelet activation in COVID-19 and vaccine-induced immune thrombotic thrombocytopenia. Front Immunol 13:837629","journal-title":"Front Immunol"},{"key":"3854_CR76","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2023.105640","volume":"92","author":"J Viskupicova","year":"2023","unstructured":"Viskupicova J, Rezbarikova P, Kovacikova L, Kandarova H, Majekova M (2023) Inhibitors of SARS-CoV-2 main protease: biological efficacy and toxicity aspects. Toxicol in Vitro 92:105640","journal-title":"Toxicol in Vitro"},{"key":"3854_CR77","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10787-021-00811-0","volume":"29","author":"A Vitiello","year":"2021","unstructured":"Vitiello A, Ferrara F (2021) Brief review of the mRNA vaccines COVID-19. Inflammopharmacology 29:645\u2013649","journal-title":"Inflammopharmacology"},{"key":"3854_CR78","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s10787-021-00847-2","volume":"29","author":"A Vitiello","year":"2021","unstructured":"Vitiello A, Ferrara F, Troiano V, La Porta R (2021) COVID-19 vaccines and decreased transmission of SARS-CoV-2. Inflammopharmacology 29:1357\u20131360","journal-title":"Inflammopharmacology"},{"key":"3854_CR79","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40264-023-01332-1","volume":"46","author":"M Walton","year":"2023","unstructured":"Walton M, Pletzer V, Teunissen T, Lumley T, Hanlon T (2023) Adverse events following the BNT162b2 mRNA COVID-19 vaccine (Pfizer-BioNTech) in Aotearoa New Zealand. Drug Saf 46:867\u2013879","journal-title":"Drug Saf"},{"key":"3854_CR80","doi-asserted-by":"crossref","first-page":"2340854","DOI":"10.1080\/21645515.2024.2340854","volume":"20","author":"D Xu","year":"2024","unstructured":"Xu D, Li J (2024) The need for development of other enterovirus vaccines in addition to EV-A71 vaccine. Hum Vaccin Immunother 20:2340854","journal-title":"Hum Vaccin Immunother"},{"key":"3854_CR81","volume":"169","author":"J Xu","year":"2022","unstructured":"Xu J, Yang W, Pan Y, Xu H, He L, Zheng B, Xie Y, Wu X (2022) Lucidenic acid A inhibits the binding of hACE2 receptor with spike protein to prevent SARS-CoV-2 invasion. Food Chem Toxicol 169:113438","journal-title":"Food Chem Toxicol"},{"key":"3854_CR82","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/toxsci\/kfab079","volume":"183","author":"S Yanagida","year":"2021","unstructured":"Yanagida S, Satsuka A, Hayashi S, Ono A, Kanda Y (2021) Comprehensive cardiotoxicity assessment of COVID-19 treatments using human-induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci 183:227\u2013239","journal-title":"Toxicol Sci"},{"key":"3854_CR83","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1016\/j.vaccine.2023.03.033","volume":"41","author":"J Yang","year":"2023","unstructured":"Yang J, Huo X, Jiang Q, Liao Y, Zhang C, Yu L, Wang Q, Niu T, Li C, Pi N, Li Y, Zhao H, Zhang Y, Tan Y, Liao W, Li Y, Fan S, Li Q (2023) Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques. Vaccine 41:2837\u20132845","journal-title":"Vaccine"},{"issue":"3","key":"3854_CR84","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.807","volume":"11","author":"F Yasmin","year":"2023","unstructured":"Yasmin F, Najeeb H, Naeem U, Moeed A, Atif AR, Asghar MS, Nimri N, Saleem M, Bandyopadhyay D, Krittanawong C, Fadelallah Eljack MM, Tahir MJ, Waqar F (2023) Adverse events following COVID-19 mRNA vaccines: a systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immun Inflamm Dis 11(3):e807","journal-title":"Immun Inflamm Dis"},{"key":"3854_CR85","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40265-024-02013-8","volume":"84","author":"C Zhu","year":"2024","unstructured":"Zhu C, Pang S, Liu J, Duan Q (2024) Current progress, challenges and prospects in the development of COVID-19 vaccines. Drugs 84:403\u2013423","journal-title":"Drugs"},{"key":"3854_CR86","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.3390\/ijms24055011","volume":"24","author":"VA Zirkenbach","year":"2023","unstructured":"Zirkenbach VA, Ignatz RM, \u00d6ttl R, Cehreli Z, Stroikova V, Kaya M, Lehmann LH, Preusch MR, Frey N, Kaya Z (2023) Effect of SARS-CoV-2 mRNA-vaccine on the induction of myocarditis in different murine animal models. Int J Mol Sci 24:5011","journal-title":"Int J Mol Sci"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03854-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-024-03854-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03854-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T10:07:02Z","timestamp":1729246022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-024-03854-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":86,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["3854"],"URL":"https:\/\/doi.org\/10.1007\/s00204-024-03854-8","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,3]]},"assertion":[{"value":"4 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no known competing financial interests or personal relationships that influenced the work here reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}